Evidence map›Paper›PMID 40493564›Full record

ArticlePloS one2025

Sage extract and ascorbic acid derivative inhibit melanogenesis via downregulating keratinocyte-derived GM-CSF.

Hirokazu Kubo, Mariko Moriyama, Saya Goto, Yuko Miyake, Maki Nakamura, Yuki Ozeki, Yukio Nakamura, Hiroyuki Moriyama

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hirokazu KuboR&D Headquarters, KOBAYASHI Pharmaceutical Co., Ltd., Ibaraki, Osaka, Japan.ORCID https://orcid.org/0009-0000-6658-4457
Mariko MoriyamaPharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0003-1277-1841
Saya GotoPharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, Japan.
Yuko MiyakePharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, Japan.
Maki NakamuraR&D Headquarters, KOBAYASHI Pharmaceutical Co., Ltd., Ibaraki, Osaka, Japan.
Yuki OzekiR&D Headquarters, KOBAYASHI Pharmaceutical Co., Ltd., Ibaraki, Osaka, Japan.
Yukio NakamuraR&D Headquarters, KOBAYASHI Pharmaceutical Co., Ltd., Ibaraki, Osaka, Japan.
Hiroyuki MoriyamaPharmaceutical Research and Technology Institute, Kindai University, Higashi-Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0001-7558-1063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salvia officinalis (sage) extract has demonstrated potential as a functional ingredient for skin care application. However, its effect and mechanism in regulating skin pigmentation remain largely unclear. This study investigated the effects of sage ethanol extract (SGE) on melanogenesis and its underlying molecular mechanisms. Treatment with SGE in a human skin equivalent model (3D-skin) suppressed melanin production. To clarify the mechanism of action, the study focused on senescence-associated secretory phenotype (SASP) factors, which are implicated in age-related pigmentation changes. q-PCR and ELISA analyses showed that SGE inhibits melanogenesis by suppressing the expression of granulocyte-macrophage colony-stimulating factor (GM-CSF), a known SASP factor in keratinocytes. Interestingly, a similar effect was observed with L-ascorbic acid 2-glucoside (AG), previously identified as a tyrosinase inhibitor. Importantly, p38 and JNK MAP-kinase were identified as upstream regulators of GM-CSF that are suppressed by SGE. These findings provide new insights into how SGE and AG regulate pigmentation via keratinocyte-derived GM-CSF, highlighting their potential in modulating skin tone and pigmentation through cellular signaling pathways.

Indexed as

Ascorbic AcidGranulocyte-Macrophage Colony-Stimulating FactorKeratinocytesMelaninsPlant ExtractsDown-RegulationHumansMelanogenesisp38 Mitogen-Activated Protein KinasesSkin PigmentationAscorbic Acidascorbic acid 2-O-glucosideGranulocyte-Macrophage Colony-Stimulating FactorMelaninsp38 Mitogen-Activated Protein KinasesPlant Extracts

Identifiers

PMID40493564
PMCPMC12151418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.